Alcon (ALC) Asset Utilization Ratio (2009 - 2026)

Alcon (ALC) posted Asset Utilization Ratio of 0.34 for Q2 2026, up 2.69% on a QoQ basis from 0.33 in Q1 2026.

Analysis

Alcon (ALC) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Alcon has reported Asset Utilization Ratio for 10 years, with the latest figure at 0.34 in Q2 2026.

On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.34 in Q2 2026; TTM through Jun 2026 was 0.34, a N/A change from a year earlier, with the FY2025 full-year figure at 0.33, up 1.62% from the prior year.
Asset Utilization Ratio was 0.34 for Q2 2026 at Alcon, up from 0.33 in the prior quarter.
The five-year high for Asset Utilization Ratio was 0.34 in Q2 2026, with the low at 0.3 in Q1 2023.
Average Asset Utilization Ratio over 5 years is 0.32, with a median of 0.32 recorded in 2023.
The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio advanced 21.7% in 2022, then declined 0.88% in 2023.
Over 5 years, Asset Utilization Ratio stood at 0.31 in 2022, then climbed by 4.53% to 0.32 in 2023, then increased by 1.29% to 0.32 in 2024, then advanced by 1.22% to 0.33 in 2025, then increased by 4.59% to 0.34 in 2026.
The last three Asset Utilization Ratio figures came in at 0.34 (Q2 2026), 0.33 (Q1 2026), and 0.33 (Q4 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	181.92 Bn	176.31 Bn	7.27 Bn	0.42
2	Intuitive Surgical	127.64 Bn	122.42 Bn	1.96 Bn	0.54
3	Medtronic	117.92 Bn	109.10 Bn	6.34 Bn	0.40
4	Stryker	105.39 Bn	101.91 Bn	4.50 Bn	0.55
5	Boston Scientific	64.88 Bn	64.34 Bn	3.85 Bn	0.47
6	Edwards Lifesciences	49.92 Bn	45.66 Bn	1.35 Bn	0.48
7	Alcon	33.24 Bn	31.79 Bn	1.68 Bn	0.34
8	Dexcom	32.12 Bn	30.18 Bn	830.00 Mn	0.76
9	Steris	20.83 Bn	20.35 Bn	684.20 Mn	0.56
10	Zimmer Biomet Holdings	17.80 Bn	17.39 Bn	1.54 Bn	0.37

Historic Data

Download Data